Silo Wellness Inc, in connection with its acquisition of Dyscovry Science Ltd.

Silo Wellness, a publicly traded company listed on the CSE, acquired 100% of the shares of Dyscovry Science Ltd. , a private company incorporated under the CBCA.

Dyscovry is a Toronto-based biotechnology company focused on biosynthetic manufacturing of psilocybin and its derivatives targeting a physiological condition, irritable bowel syndrome.